Consistent with previous reports, NAFLD patients exhibited markedly higher CK18 levels than those with simple steatosis, and CK18 correlated positively with ALT, supporting its utility as a biochemical indicator of hepatocellular injury [25]. Here, KRT18 is linked to metabolic dysfunction-associated steatotic liver disease.